Adagene Inc. Sponsored ADR (ADAG) vs Veraxa Biotech AG (VRXA)

Adagene Inc. Sponsored ADR ADAG 2.00 −0.99%
Veraxa Biotech AG VRXA 0.95 0.00%

Adagene Inc. Sponsored ADR and Veraxa Biotech AG are both Biotechnology companies. Adagene Inc. Sponsored ADR and Veraxa Biotech AG are of similar size ($140.4M and $134.3M).

Metric	ADAG	VRXA	Biotechnology median
P/E	—	—	10.60
P/S	—	—	9.40
P/B	n/m	—	2.13
Price to free cash flow	n/m	—	25.18
EV/EBITDA	n/m	—	0.66
EV/Sales	n/m	—	9.02
Earnings yield	—	—	(32.88%)
Free cash flow yield	0.00%	—	(23.13%)

Metric	ADAG	VRXA	Biotechnology median
Gross margin	—	—	68.51%
Operating margin	—	—	0.00%
Net margin	—	—	0.00%
Free cash flow margin	0.00%	—	0.00%
Return on equity	0.00%	—	(51.96%)
Return on assets	0.00%	—	(46.06%)
Return on invested capital	0.00%	—	0.00%

Metric	ADAG	VRXA	Biotechnology median
Revenue growth (TTM)	—	—	6.76%
EPS growth (last fiscal year)	49.15%	—	29.88%
Revenue growth, 5-year CAGR	61.38%	—	9.75%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	ADAG	VRXA	Biotechnology median
Debt to equity	0.01	—	0.00
Current ratio	5.02	—	4.97
Net debt to EBITDA	3.46	—	1.01

Metric	ADAG	VRXA	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	ADAG	VRXA	Biotechnology median
Market cap	134.28m	140.35m	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack